Dirk Koczan
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Cancer, Hypoxia, and Metabolism 10
- MicroRNA in disease regulation 9
- Immunology 35
- Co-authors
- Hans‐Jürgen ThiesenSaleh IbrahimHans‐Juergen ThiesenMichael HeckerManfred KunzUwe K. ZettlReinhard GuthkePeter Lorenz
- Journals
- Arthritis Research & Therapy (10 papers)BMC Genomics (8 papers)PLoS ONE (5 papers)Journal of Neuroinflammation (3 papers)Molecular Cytogenetics (3 papers)
- Partner nations
- GermanyUnited StatesCroatia
In The Last Decade
Dirk Koczan
197 papers receiving 5.8k citations
Peers
Comparison fields: 5 of 153
- Immunology 1.4k
- Cancer Research 941
- Rheumatology 861
- Oncology 1.3k
- Molecular Biology 2.6k
Countries citing papers authored by Dirk Koczan
This map shows the geographic impact of Dirk Koczan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Koczan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Koczan more than expected).
Fields of papers citing papers by Dirk Koczan
This network shows the impact of papers produced by Dirk Koczan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Koczan. The network helps show where Dirk Koczan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dirk Koczan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2021 | 10 | |
| 7 | 2020 | 7 | |
| 8 | 2020 | 7 | |
| 9 | 2019 | 51 | |
| 10 | 2019 | 10 | |
| 11 | 2018 | 13 | |
| 12 | 2018 | 19 | |
| 13 | 2018 | 14 | |
| 14 | 2016 | 15 | |
| 15 | 2012 | 7 | |
| 16 | 2011 | 9 | |
| 17 | 2008 | 49 | |
| 18 | 2007 | 175 | |
| 19 | 2006 | 24 | |
| 20 | 2006 | 6 |
About Dirk Koczan
Dirk Koczan is a scholar working on Cancer Research, Immunology, Rheumatology, Oncology and Molecular Biology, having authored 198 papers that have together received 5.9k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (16 papers), Rheumatoid Arthritis Research and Therapies (16 papers), Multiple Sclerosis Research Studies (14 papers), RNA Research and Splicing (11 papers), Gene expression and cancer classification (11 papers), Cancer, Hypoxia, and Metabolism (10 papers), MicroRNA in disease regulation (9 papers) and Molecular Biology Techniques and Applications (9 papers). The work is most often cited by research in Immunology (1.4k citations), Cancer Research (941 citations), Rheumatology (861 citations), Oncology (1.3k citations) and Molecular Biology (2.6k citations). Dirk Koczan has collaborated with scholars based in Germany, United States and Croatia. Frequent co-authors include Hans‐Jürgen Thiesen, Saleh Ibrahim, Hans‐Juergen Thiesen, Michael Hecker, Manfred Kunz, Uwe K. Zettl, Reinhard Guthke, Peter Lorenz, P Stiehl and Gerd Hobom. Their work appears in journals such as Arthritis Research & Therapy, BMC Genomics, PLoS ONE, Journal of Neuroinflammation and Molecular Cytogenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.